The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans
Drug Metabolism and Disposition · 2024-10 · 52 (10) · 1124-1136
DOI: 10.1124/dmd.124.001843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2024-10. Verfasst von Jonathan N Bauman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S.…. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C…
ORCID-Profile: Matthew A Cerny, Martin E Dowty
Zitieren
APA
Bauman, J. N., Doran, A. C., Gualtieri, G. M., Hee, B., Strelevitz, T., Cerny, M. A., Banfield, C., Plotka, A., Wang, X., Purohit, V. S., & Dowty, M. E. (2024). The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans. Drug Metabolism and Disposition, 52(10), 1124-1136. https://doi.org/10.1124/dmd.124.001843
Vancouver
Bauman JN, Doran AC, Gualtieri GM, Hee B, Strelevitz T, Cerny MA, et al. The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans. Drug Metabolism and Disposition. 2024;52(10):1124-1136. doi:10.1124/dmd.124.001843
BibTeX
@article{Bauman2024,
author = {Bauman, Jonathan N and Doran, Angela C and Gualtieri, Gabrielle M and Hee, Brian and Strelevitz, Timothy and Cerny, Matthew A and Banfield, Christopher and Plotka, Anna and Wang, Xiaoxing and Purohit, Vivek S and Dowty, Martin E},
title = {The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans},
journal = {Drug Metabolism and Disposition},
year = {2024},
volume = {52},
number = {10},
pages = {1124--1136},
doi = {10.1124/dmd.124.001843}
}
EUVIMED